Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2012
05/31/2012CA2818007A1 Multicomponent system of rosuvastatin calcium salt and sorbitol
05/30/2012EP2457940A1 Fluorinated supramolecular polymers
05/30/2012EP2456778A1 Process for producing flurocytidine derivatives
05/30/2012EP2456761A2 Potent small molecule inhibitors of autophagy and methods of use thereof
05/30/2012EP2456435A1 Heteroaryl benzamides, compositions and methods of use
05/30/2012EP2137166B1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
05/30/2012EP1670787B1 Cytokine inhibitors
05/30/2012CN102482286A Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
05/30/2012CN102482233A 新颖的嘧啶衍生物和它们在治疗癌症和其它疾病中的用途 Novel pyrimidine derivatives and their use in the treatment of cancer and other diseases
05/30/2012CN102482232A 新的嘧啶和三嗪铁调素拮抗剂 New pyrimidine and triazine hepcidin antagonist
05/30/2012CN102482231A 磺酰胺和磺基肟-取代的二芳基-二氢嘧啶酮和其应用 Sulfonamides and sulfonamide oxime - substituted diaryl - dihydro-pyrimidone and their applications
05/30/2012CN102482212A Carboxamide compounds and their use as calpain inhibitors
05/30/2012CN102477015A 一种洛美曲索中间体的合成方法 One method of synthesis intermediates lometrexol
05/30/2012CN102477001A Benzamide histone deacetylase inhibitor
05/30/2012CN101735201B Preparation method of piribedil
05/30/2012CN101421243B Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
05/30/2012CN101370789B Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
05/29/2012USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them
05/29/2012US8188324 Coating interior surface of chemical reactor with lithium aluminum hydride; supplying carbon dioxide; reduction; reacting with hydrogen iodide
05/29/2012US8188301 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188274 Process for preparing aminocrotonylamino-substituted quinazoline derivatives
05/29/2012US8188269 Functionalized compositions for improved immobilization
05/29/2012US8188104 Anti-infective agents and uses thereof
05/29/2012US8188103 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
05/29/2012US8188096 Protein kinase targeted therapeutics
05/29/2012CA2682849C Sulfonamides and pharmaceutical compositions thereof
05/29/2012CA2592286C Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2521425C Substituted phenoxy-acetic acids
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/29/2012CA2318731C Ppar-gamma modulators
05/24/2012WO2012068109A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/24/2012WO2012067824A1 Potassium channel modulators
05/24/2012WO2012067269A1 Aminoalkoxyphenyl compounds and their use in the treatment of disease
05/24/2012WO2012066365A2 Crystalline pharmaceutically active ingredients
05/24/2012WO2012066336A1 Benzylamine compounds as toll -like receptor 7 agonists
05/24/2012WO2012066335A1 Phenol compounds als toll -like receptor 7 agonists
05/24/2012WO2012065574A1 Substituted pyrimidine ammonia compound and use thereof
05/24/2012WO2012017448A3 Salts of lapatinib
05/24/2012WO2012008711A3 Erlotinib dichloroacetate and anti-cancer agent comprising the same
05/24/2012US20120130058 Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine
05/24/2012US20120129840 Novel viral replication inhibitors
05/24/2012CA2818125A1 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/24/2012CA2816952A1 Crystalline pharmaceutically active ingredients
05/23/2012EP2455371A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
05/23/2012EP2455367A1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/23/2012CN102471288A Method for stereoselective synthesis of bicyclic heterocyclic compounds
05/23/2012CN102471287A 2-氨基-5-三氟甲基嘧啶衍生物的区域选择性制备方法 2-amino-5-trifluoromethyl-pyrimidine derivatives regioselective preparation of
05/23/2012CN102471286A 苯基(氧基/硫基)烷醇衍生物 (Oxy / thio) phenyl alcohol derivatives
05/23/2012CN102471285A 取代的苯基(氧基/硫基)烷醇衍生物 Substituted (oxy / thio) phenyl alkanol derivative
05/23/2012CN102471284A 作为p2x7调节剂的二氢嘧啶酮酰胺 As dihydropyrimidinone amide p2x7 moderator
05/23/2012CN102470127A 联芳基化合物和其使用方法 Biaryl compounds and their use
05/23/2012CN102464622A Substituted pyrimidine ammine compound and application thereof
05/23/2012CN102464621A 含嘧啶环的醚类化合物及其应用 Ether compounds containing a pyrimidine ring and its applications
05/23/2012CN102464612A 含哌嗪氨基甲酸酯的二卤丙烯醚类化合物与应用 Piperazine-containing urethane-dihalo ether compound of propylene and Applications
05/23/2012CN102464592A 酰基苄胺类化合物及其应用 Acyl, benzyl amine compounds and their application
05/23/2012CN102070538B Method for preparing azoxystrobin
05/23/2012CN101851241B Anti-tumor compound and preparation method and application thereof
05/23/2012CN101759652B Method for synthesizing spirocyclic compound
05/23/2012CN101463011B Process for synthesizing 3,4-dihydropyrimidine-2-keto
05/23/2012CN101323598B Preparation of 5,5-diethylmalonylurea
05/22/2012US8183397 Synthesis of statins
05/22/2012US8183252 Heterocyclic aspartyl protease inhibitors
05/22/2012US8183251 1-[(4S)-4-cyclopropyl-2,5-dioxoimidazolidin-4-yl]-N-methyl-N-{[4-(pyrimidin-5-yloxy)phenyl]methyl}methanesulfonamide; matrix metalloproteinase inhibitors; obstructive airways disease is asthma or chronic obstructive pulmonary disease
05/22/2012US8183250 Potent PARP inhibitors
05/22/2012US8183242 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
05/22/2012CA2624045C Process for the manufacture of quinazoline derivatives
05/22/2012CA2540501C Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
05/18/2012WO2012064706A1 Mutant-selective egfr inhibitors and uses thereof
05/18/2012WO2012063115A2 Process for the preparation of rosuvastatin calcium via novel amine intermediate
05/18/2012WO2012062704A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
05/18/2012WO2012062413A1 Non metal tanning
05/18/2012CA2817541A1 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
05/18/2012CA2815330A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
05/17/2012US20120123118 Process For The Preparation Of Nitroorotic Acid
05/17/2012US20120123114 Quinazoline derivatives having tyrosine kinase inhibitory activity
05/17/2012US20120123026 Functionalized compositions for improved immobilization
05/17/2012US20120122946 Polymorphisms for predicting disease and treatment outcome
05/17/2012US20120122903 1-h-quinazoline-2, 4-diones for use in the treatment of neuronal ceroid lipofuscinosis
05/17/2012US20120122902 Pyrimidine derivative, preparation method and use thereof
05/17/2012US20120122891 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
05/17/2012US20120122890 Potassium Channel Modulators
05/17/2012US20120122867 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122819 Guanine riboswitch binding compounds and their use as antibiotics
05/17/2012US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/16/2012EP2452997A2 Compound for an organic photoelectric element, and an organic photoelectric element comprising the same
05/16/2012EP2452935A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/16/2012EP2451788A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl]-benzoylamino} -4-methylen -penta nedioic acid
05/16/2012EP2451787A1 Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]
05/16/2012EP2451786A2 Improved process for the preparation of ambrisentan and novel intermediates thereof
05/16/2012EP2451785A2 Substituted phenyl(oxy/thio)alkanol derivatives
05/16/2012EP2451784A1 Phenyl(oxy/thio)alkanol derivatives
05/16/2012EP2268625B1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
05/16/2012EP1934233B1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
05/16/2012EP1851199B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 427